Products

EngageGPT

AI-nativeMCP

Supercharge your LinkedIn engagement

engagegpt.in Chrome Web StoreMarketing / Social Account Growth

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Monthly revenue
$9.01
Down3.6%MoMSep 2026
Entry price
Usage-based
No monthly subscription pricing
Creators
Unlinked
No verified creators
Launched
2y ago
2024-05-05 · Est.

Traffic & revenue

Monthly visitsData through Oct 2026
Verified monthly revenueRevenue data stopped at 2026-10-09

Marketing moves

Launches, search & content, referrals, promotions
  • New product launchLaunch

    May 5, 2024 · 2y agoWebsite

MCP Server & Agent Ecosystem

GitHub · MCP / Skill

Agent, MCP & Developer Integration

MCP Server
Ecosystem & integrations:
LinkedInClaude
Browse all MCP Server products →

Traffic sources

Oct 2026

Traffic breakdown

Channels

  • Direct39%
  • Organic Search30%
  • Referrals10%
  • Social6%
  • Other14%

Countries

No data yet

Search

Domain authority 2Domain registered 2024-05-05

KeywordMonthly volume
engage ai1,220
aiengage120
gengage ai60

Traffic data: Vaneform

Pricing

Usage-based pricing; no fixed plans listed on website.

Trial: None · Observed 2026-11-04 · Source page

Website snapshots

Indexed 2026-07-30

Key pages

Desktop & mobile archive
Home
www.engagegpt.in/ Snapshot 2026-11-04

Questions & evidence

How much website traffic does EngageGPT get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is EngageGPT and what platforms does it support?
EngageGPT is catalogued under Social Account Growth: Supercharge your LinkedIn engagement. Supported platforms: Browser Extension, MCP Server.
What is EngageGPT's publicly disclosed revenue?
TrustMRR records verified monthly revenue of $9.01 in 2026-09.Source

Related products in this category

Marketing / Social Account Growth

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.